Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Receivables - Other: 2020-2024

Historic Receivables - Other for iSpecimen (ISPC) over the last 4 years, with Sep 2024 value amounting to $1.7 million.

  • iSpecimen's Receivables - Other rose 16.04% to $1.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.7 million, marking a year-over-year increase of 16.04%. This contributed to the annual value of $2.2 million for FY2023, which is 4.95% down from last year.
  • Per iSpecimen's latest filing, its Receivables - Other stood at $1.7 million for Q3 2024, which was down 15.34% from $2.0 million recorded in Q2 2024.
  • In the past 5 years, iSpecimen's Receivables - Other ranged from a high of $2.3 million in Q4 2022 and a low of $652,761 during Q4 2020.
  • Over the past 3 years, iSpecimen's median Receivables - Other value was $1.6 million (recorded in 2023), while the average stood at $1.6 million.
  • In the last 5 years, iSpecimen's Receivables - Other soared by 166.41% in 2021 and then declined by 25.10% in 2022.
  • Quarterly analysis of 5 years shows iSpecimen's Receivables - Other stood at $652,761 in 2020, then skyrocketed by 166.41% to $1.7 million in 2021, then soared by 33.86% to $2.3 million in 2022, then dropped by 4.95% to $2.2 million in 2023, then increased by 16.04% to $1.7 million in 2024.
  • Its Receivables - Other was $1.7 million in Q3 2024, compared to $2.0 million in Q2 2024 and $2.0 million in Q1 2024.